ARCH Advanced Revascularization Symposium
B

Building a Robust Left Atrial Appendage Closure (LAAC) Program

By ARCH Advanced Revascularization Symposium FEATURING Bryan Cogar
By ARCH Advanced Revascularization Symposium FEATURING Bryan Cogar
103 views
May 15, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
31
Boston Scientific

Proven to Reduce NVAF Stroke Risk for Life

31
Boston Scientific

Designed to Protect a Broad Range of Patients

31
Boston Scientific

Clinically Proven to Safely & Effectively Reduce NVAF Stroke Risk

31
Boston Scientific

Advancing Safety & Simplicity in LAAC - See the Difference

31
Boston Scientific

Patient Eligibility Criteria

31
Boston Scientific

Most Studied & Implanted LAAC Device

31
Boston Scientific

Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Trial Data

31
Boston Scientific

Proven Safety & Advanced Procedural Performance

08:15
Georgia Heart Institute

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Feat. D. Weisman, C. Ellis
04:43
Boston Scientific

TCT 2023: Transseptal Access for LAAC - My Experience in Increased E…

Feat. N. Sawlani
18:26
Stanford Medicine

When Is LAA Closure Device an Option?

Feat. C. Liu
31
Boston Scientific

Advancing Safety In LAAC

14:16
Penn Medicine Heart and Vascular Center

Stroke Prevention in Atrial Fibrillation

Feat. D. Goldberg
14:47
ACC 2023 Conference Coverage

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

Feat. A. Natale
07:26
Boston Scientific

TCT 2023: My Journey in Optimizing Structural Heart Procedures

Feat. J. Aragon
28:34
Vivek Reddy

Percutaneous Left Atrial Appendage Closure using the Watchman Device

14:23
The Texas Heart Institute

Atrial Fibrillation: New Treatments

Feat. J. Cozart
08:06
AtriCure

Updates in the Treatment of Complex and Persistent Atrial Fibrillati…

Feat. R. Tung, R. Lee
16:28
Piedmont Heart Institute Napa Valley Cardiology Conference

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

Feat. T. Deering